From April 1, 2024 to April 9, 2024, the company has repurchased 285,400 shares, representing 0.06% for CNY 15.24 million. With this, the company has completed the repurchase of 1,781,400 shares, representing 0.38% for CNY 99.99 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.97 CNY | -2.73% | -10.52% | -44.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.11% | 2.25B | |
-16.99% | 8.67B | |
+68.23% | 4.25B | |
-1.10% | 2.51B | |
-9.46% | 2.47B | |
-8.37% | 1.91B | |
-19.29% | 1.56B | |
-41.75% | 1.19B | |
+11.31% | 1.15B | |
+14.87% | 964M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.